Ghassan Abou-Alfa: The New Standard for Screening Abbreviated MRI Plus AFP
Ghassan Abou-Alfa/genosciencepharma.com

Ghassan Abou-Alfa: The New Standard for Screening Abbreviated MRI Plus AFP

Ghassan Abou-Alfa, Medical Oncologist at Memorial Sloan Kettering Cancer Center, shared a post on X about a recent article he and his colleagues co-authored, adding:

“The new standard for screening abbreviated MRI plus AFP? (PREMIUM study) – JHEP Reports.

Memorial Sloan Kettering Cancer Center Department of Medicine is proud to have contributed to the published effort.”

Title: Practice changing RCT design and rationale: Abbreviated MRI plus AFP vs.ultrasound plus AFP for HCC surveillance in cirrhosis (PREMIUM study)

Authors: George N. Ioannou, Tamar H. Taddei, Beata M. Planeta, Grant D. Huang, Noel S. Weiss, Timothy R. Morgan, Jason A. Dominitz, Ghassan K. Abou-Alfa, Mustafa R. Bashir, Michael V. Beheshti, Amit G. Singal, Cynthia A. Moylan, Robin J. Boland, Lynn F. Buchwalder, Rajni L. Mehta, Kimberly S. Hoisington, Nhan V. Do, Shari S. Rogal, David E. Kaplan, Jihane N. Benhammou, Grace L. Su, Linda M. McDonald, Genta Dani, Dell P. Dunn, Stephanie T. Chang, Ifeyinwa Y. Onyiuke, Ashu Sharma, Tassos C. Kyriakides

Read the Full Article on JHEP Reports

Ghassan Abou-Alfa: The New Standard for Screening Abbreviated MRI Plus AFP

More posts featuring Ghassan Abou-Alfa.